MARKET

XBI

XBI

SPDR® S&P Biotech ETF
NYSEARCA
91.83
-5.13
-5.29%
Pre Market: 92.43 +0.6 +0.65% 04:17 11/18 EST
OPEN
96.91
PREV CLOSE
96.96
HIGH
96.91
LOW
91.64
VOLUME
200
TURNOVER
0
52 WEEK HIGH
105.47
52 WEEK LOW
64.89
TOTAL ASSET
7.61B
YTD YIELD
29.75%
1D
5D
1M
3M
1Y
5Y
1D
Trump Taps RFK for HHS: Time to Avoid Biotech?
NASDAQ · 2d ago
Continuously high dispersion in the markets could make it a ‘picker’s market’
Seeking Alpha · 2d ago
Trump Names Anti-Vaxxer Robert Kennedy As Health & Human Services Secretary: Here’s What It Means For Healthcare Stocks
Barchart · 3d ago
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
MarketWatch · 3d ago
The U.S. Shakes Up Global Pharma Supply Chains
Seeking Alpha · 3d ago
Why Healthcare Investors Shouldn't Bank On Drug Pipelines
Seeking Alpha · 4d ago
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday
Barchart · 5d ago
Altimmune Stock Goes Parabolic Following Q3 Results As CEO Touts 2025 As ‘Transformational Year:’ Retail Upbeat
Barchart · 5d ago
More
Profile
Fund Name
SPDR® S&P Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P Biotechnology Select Industry TR USD
Advisor Company
SPDR State Street Global Advisors
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Raymond Donofrio, Karl Schneider